Sofia Fund
Minneapolis, Minnesota, United States
Overview
Sofia Fund invests in women-led, technology-based, and business growth. It uncovers and qualifies only the best investment opportunities from thousands of ideas through extensive due diligence and then actively invests to grow its portfolio companies and bring them successfully to profitable exits. Its main office is in Minneapolis, Minnesota and it was founded in 2006.
- Total investments
- 9
- Lead investments
- 3
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Health Care
- Information Technology
- Internet
- Mobile
- Software
Investment portfolio
- ExplORer Surgical
Participated · Equity · Apr 2021
ExplORer Surgical offers a platform that combines video, role-specific digital procedural playbooks, and time-stamped intraoperative data capture to support virtual proctoring, case support, clinical trials data collection, and product launches. The company originated from a research laboratory in the University of Chicago Medical Center Department of Surgery and integrates remote, HIPAA-compliant two-way video connectivity so offsite team members can join procedures. Its Remote Case Support feature, launched in early 2020, drove a 6X increase in sales over the last year. ExplORer has built more than 1,000 unique procedures on its platform and onboarded over 10 new medical device customers in under three months, including large global MedTech companies and startups. The company plans to use the new funding to grow headcount from about 30 to roughly 50, expand technology, marketing, and customer success teams, and deliver additional platform updates; it also expects to raise another round later this year. ExplORer Surgical offers a software-as-a-service platform for intraoperative surgical and interventional procedure workflow management and analytics. The platform lets hospital and device company teams guide, track and analyze activity in the operating room, during training events and throughout stages of clinical use. Each team member sees their own content on any connected device, and the system collects live procedural data. Led by CEO and co-founder Jennifer Fried, the company is based in Chicago, IL. ExplORer intends to use the recently raised funds to accelerate growth of its surgical software platform. The article does not disclose revenue or user metrics. ExplORer Surgical offers a software-as-a-service interactive digital playbook to manage, track and analyze intra-operative activity and information for operating rooms and interventional suites. The platform supports team coordination during procedures and delivers granular analytics on procedure activity. Customers include hospitals and medical device manufacturers that use the tool to improve intraoperative workflow and data capture. The company was founded out of a research laboratory at the University of Chicago Medical Center and is led by CEO Jennifer Fried. ExplORer intends to use the new financing to accelerate commercialization of its workflow management platform. The company is based in Chicago, Illinois. ExplORer Surgical builds an interactive surgical playbook as a software-as-a-service intraoperative workflow management tool. The platform aims to optimize operating room teamwork by preventing delays and disruptions caused by missing or incorrect instruments. It also seeks to reduce instances of opened-but-unused disposable items and to capture granular intraoperative data in real time. The company is led by CEO and co-founder Jennifer Fried, with Dr. Alex Langerman as Chief Medical Officer, Dr. Marko Rojnica, Eugene Fine as CTO, and Tom Knight as COO. ExplORer says it will use the funding to scale operations.
- StormSensor
Led · Equity · Jan 2020
StormSensor develops rugged sensors that monitor stormwater flow and temperature and a software platform that ingests sensor data plus rainfall, wind and tide information to provide real-time alerts and insights. The company focused on engineering hardware that can survive underground metal and concrete vaults with contaminated water and on software that makes sense of that data. Its platform is being enhanced with more sophisticated analysis to show infrastructure performance across varied weather events and timescales. StormSensor also offers a risk index to highlight flood-prone and equity‑vulnerable neighborhoods. The startup serves municipalities ranging from 5,000 to 1,000,000 residents across the U.S., with many customers on the East Coast, the Southeast and around the Great Lakes. The company has 37 employees and has raised about $16 million in total investments to date. StormSensor develops compact, 3D-printed sensors and climate-intelligence systems that monitor water flow, temperature, and precipitation in municipal storm drains to help cities manage floods, storm surges, and sea-level rise. The company began as a prototype effort and has streamlined a formerly 3-foot epoxy prototype into a palm-sized device intended for large-scale manufacturing and wider deployment. Founder Erin Rothman launched the company in 2015 and bootstrapped it through $1.2M from friends and angel investors plus $155,000 from 9Mile Labs and Techstars accelerators. After losing expected Series A funding in March 2020, the team raised an emergency $2M seed round in two weeks to keep the business alive and retain staff. StormSensor is deployed in 12 U.S. cities and aims to expand beyond those municipalities and to work with developing countries. The company plans to scale manufacturing, expand deployments, and hire additional staff to support product development and operations. StormSensor, a Seattle startup founded in 2015, sells wireless sensors paired with software to replace manual stormwater quality reporting with a fully digital solution. Its system uses predictive algorithms to track stormwater data and identify high-risk locations for flooding and sewer overflows. Customers include municipalities such as Jersey City, which uses the technology to pinpoint problem sites and inform interventions. The company competes with Teledyne/ISCO, Campbell Scientific, YSI, and ADS. StormSensor graduated from the 9MileLabs accelerator (which closed in 2016), appeared on GeekWire’s Elevator Pitch show, and is led by CEO and co-founder Erin Rothman; co-founder Anya Stettler left in late 2018. The nine-person company recently raised $585,000 and has total funding to date of $2.6 million, and it plans to raise additional investment later this year.
- Oculogica
Led · Equity · Jan 2020
Oculogica develops EyeBOX, an eye-tracking, FDA-cleared, baseline-free aid for diagnosing and categorizing concussion. The EyeBOX is a four-minute test intended for ages 5 to 67 and is already used by leading healthcare organizations. The company announced a $2 million U.S. Army Medical Research and Development Command (USAMRDC) grant to develop a wearable version of its technology for deployed and far-forward settings. That effort will involve partners including Keller Army Hospital at West Point, The Geneva Foundation, Children’s Hospital of Philadelphia, and the University of Wisconsin–Green Bay. AdHawk Microsystems’ camera-free eye-tracking technology will be a critical component of the new wearable device. Oculogica has previously received grants from the NIH and the FDA; the USAMRDC award is the largest grant the company has received to date. Oculogica is the company behind the EyeBOX device. The EyeBOX is being distributed at Level I, II and III trauma centers nationwide. The company recently closed an $8 million financing round. Sofia Fund, an existing backer, participated in the round. Proceeds will support further commercial distribution and deployment, including additional units for use with the U.S. Department of Defense.
- Clinician Nexus
Participated · Seed · Dec 2019
Clinician Nexus built a platform that lets health systems, schools and students connect so providers can post rotation schedules and students can book training. The system centralizes paperwork for schools, providers and students to streamline onboarding. Students training in nursing, physician assistant and medical doctor programs use the platform across a range of clinical disciplines. The company says its first customer realized over 50% time savings in onboarding students coming from over 150 schools across the globe. In late December Clinician Nexus picked up $1.5 million in a seed funding round, bringing total investment to $2.3 million. Leadership signaled the funds will support platform growth and further building of the clinical education community.
- Knowledge to Practice
Participated · Equity · Dec 2019
Knowledge to Practice (K2P) provides a personalized, competency-based SaaS platform and microlearning curriculum for physicians across acute, in‑patient, and out‑patient settings. The platform combines high-quality content, assessments, and applies technologies such as artificial intelligence and natural language processing to personalize learning and enable clinicians to monitor mastery. K2P aims to reduce skill inequity, drive continuity of care, and improve population health by changing how education is delivered to interdisciplinary care teams. The company reports its personalized curriculum yields an average 56% improvement in knowledge retention and recall over six months versus 3–5% for older continuing medical education models. K2P has raised $3.7M in new funding to accelerate expansion of its portfolio and scale its enterprise offering to health systems nationwide. Investors continue to position K2P to build learning organizations within hospital systems and foster a more engaged, confident workforce. Knowledge to Practice provides postgraduate medical education through a subscription model designed to motivate clinicians to maintain certification and improve team-based, patient-centered care. The company reports reaching 3,564 clinicians more than 325,000 times as of Feb. 1. Founded in 2015, it targets continuing-education needs of clinical teams (no revenue figures disclosed). The company recently pursued near-term capital, filing a private securities offering (Form D) and raising external funding. It raised $6.5M and signaled plans to raise an additional ~$498K to support growth and operations. CEO Mary Ellen Beliveau, who signed the Form D, has led the company since December 2013 and previously served as senior vice president and chief learning officer at the American College of Cardiology.
Team
No current team members are available.